Large-scale testing (Phase 3)Study completedNCT01245764
What this trial is testing
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 250